Accordingly, a thorough comparison was performed in vitro, followed by selecting the optimized NPs in order to be a potential carrier for the IN application of insulin, a potential anti-AD drug, with the aim of brain-targeting. The gene discussed is INS; the disease is Alzheimer disease.